Treatment of myocardial fibrosis in systemic sclerosis with tocilizumab

Rheumatology (Oxford). 2021 Jun 18;60(6):e205-e206. doi: 10.1093/rheumatology/keaa865.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Cardiomyopathies / drug therapy*
  • Cardiomyopathies / etiology
  • Fatty Acids / pharmacokinetics
  • Female
  • Fibrosis
  • Humans
  • Iodobenzenes / pharmacokinetics
  • Mycophenolic Acid / therapeutic use
  • Myocardium / pathology*
  • Scleroderma, Systemic / complications
  • Scleroderma, Systemic / drug therapy*

Substances

  • Antibodies, Monoclonal, Humanized
  • Fatty Acids
  • Iodobenzenes
  • iodofiltic acid
  • Mycophenolic Acid
  • tocilizumab